Penumbra Stock Forecast
NYSE: PENHealth CareMedical/Dental InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
PEN analyst consensus
Consensus (16 analysts)
hold
Avg. price target
$361.58+13.21%
- Strong buy 1
- Buy 2
- Hold 13
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 16 Wall Street analysts covering Penumbra (2026-10-07), 3 rate the stock a buy or strong buy, 13 rate it a hold and 0 rate it a sell or strong sell, for a consensus rating of "hold". The average 12-month price target is $361.58, with a high estimate of $374.00 and a low estimate of $320.00. The average target implies upside of 13.2% from the current price of $319.40.
The spread between the highest and lowest targets is 16.9%, a relatively narrow range. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for PEN.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 1 | 6% |
| Buy | 2 | 13% |
| Hold | 13 | 81% |
| Sell | 0 | 0% |
| Strong sell | 0 | 0% |
Ratings as of 2026-10-07.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $320.00 | +0.19% |
| Average target | $361.58 | +13.21% |
| High target | $374.00 | +17.09% |